Skip to main content
. 2022 Aug 30;5(8):e2229247. doi: 10.1001/jamanetworkopen.2022.29247

Table 2. Estimated Primary Outcomes From Fully Adjusted Regression Modelsa.

Covariate Receipt of surgery, overall cohort (N = 57 710) Surgical cohort (n = 37 691)
Emergent surgery MIS Surgical complications Mortality
HR (95% CI) P value OR (95% CI) P value OR (95% CI) P value OR (95% CI) P value OR (95% CI) P value
Region
Metropolitan 1 [Reference] NA 1 [Reference] NA 1 [Reference] NA 1 [Reference] NA 1 [Reference] NA
Micropolitan 1.05 (1.02-1.08) <.001 1.25 (1.14-1.37) <.001 0.70 (0.66-0.75) <.001 1.09 (0.99-1.20) .08 0.96 (0.86-1.08) .52
Small town or rural 1.09 (1.05-1.12) <.001 1.32 (1.20-1.44) <.001 0.75 (0.70-0.80) <.001 1.08 (0.99-1.19) .09 0.88 (0.78-0.99) .03
Race and ethnicity
Hispanic 0.96 (0.91-1.01) .11 1.03 (0.87-1.23) .70 1.02 (0.91-1.14) .73 1.11 (0.95-1.31) .19 0.99 (0.81-1.22) .95
Non-Hispanic Black 0.92 (0.88-0.95) <.001 1.00 (0.88-1.15) .95 0.93 (0.85-1.02) .12 1.03 (0.90-1.17) .69 1.04 (0.89-1.22) .60
Non-Hispanic White 1 [Reference] NA 1 [Reference] NA 1 [Reference] NA 1 [Reference] NA 1 [Reference] NA
Non-Hispanic other 0.95 (0.91-1.01) .08 1.03 (0.87-1.23) .72 1.21 (1.08-1.35) <.001 1.01 (0.85-1.19) .92 0.81 (0.64-1.03) .08
Full dual eligibility (vs not) 0.97 (0.93-1.01) .14 1.44 (1.27-1.64) <.001 0.87 (0.79-0.96) <.001 1.14 (1.00-1.30) .05 1.30 (1.12-1.51) <.001
ADI, every 10 ranks 1.00 (1.00-1.01) <.001 1.03 (1.02-1.05) <.001 0.93 (0.92-0.94) <.001 1.02 (1.01-1.03) .01 1.07 (1.05-1.08) <.001
Age category, y
65-70 1 [Reference] NA 1 [Reference] NA 1 [Reference] NA 1 [Reference] NA 1 [Reference] NA
71-75 1.00 (0.97-1.03) .98 1.11 (1.00-1.23) .05 1.00 (0.94-1.06) .98 1.04 (0.94-1.16) .42 1.31 (1.10-1.57) <.001
76-80 0.97 (0.94-1.00) .05 1.37 (1.24-1.51) <.001 0.89 (0.84-0.95) <.001 1.04 (0.94-1.15) .47 1.95 (1.64-2.31) <.001
81-85 0.97 (0.94-1.00) .09 1.73 (1.55-1.92) <.001 0.73 (0.68-0.78) <.001 1.02 (0.91-1.14) .76 2.64 (2.23-3.13) <.001
>85 0.90 (0.86-0.93) <.001 2.97 (2.66-3.31) <.001 0.54 (0.50-0.59) <.001 1.03 (0.92-1.16) .57 4.26 (3.61-5.02) <.001
Female sex 1.05 (1.03-1.07) <.001 1.11 (1.00-1.23) .05 0.97 (0.93-1.02) .22 0.89 (0.84-0.95) <.001 0.81 (0.75-0.88) <.001
Side of colon cancer
Left 1 [Reference] NA 1 [Reference] NA 1 [Reference] NA 1 [Reference] NA 1 [Reference] NA
Right 1.65 (1.61-1.69) <.001 0.79 (0.73-0.85) <.001 1.33 (1.26-1.39) <.001 0.77 (0.72-0.83) <.001 1.11 (1.02-1.22) .02
Unspecified 0.17 (0.16-0.18) <.001 0.92 (0.78-1.08) .31 0.99 (0.89-1.11) .87 1.01 (0.86-1.18) .93 0.27 (0.23-0.32) <.001
Diabetes 1.02 (1.00-1.05) .11 0.76 (0.70-0.83) <.001 1.04 (0.98-1.09) .19 1.08 (0.99-1.16) .07 1.00 (0.91-1.10) .96
MI 1.09 (0.97-1.21) .14 0.88 (0.62-1.26) .49 1.12 (0.89-1.41) .34 0.98 (0.72-1.35) .92 0.94 (0.67-1.31) .71
CHF 1.05 (1.00-1.10) .06 0.91 (0.79-1.05) .21 1.03 (0.93-1.13) .62 1.11 (0.97-1.28) .14 1.08 (0.94-1.25) .29
Stroke or TIA 1.10 (1.03-1.19) .01 0.93 (0.74-1.18) .55 1.06 (0.91-1.24) .47 0.99 (0.79-1.23) .92 0.88 (0.69-1.13) .33
COPD 0.99 (0.96-1.04) .80 1.03 (0.91-1.17) .61 0.93 (0.85-1.01) .08 1.00 (0.88-1.13) >.99 1.41 (1.24-1.60) <.001
End-stage kidney disease 0.90 (0.81-0.99) .03 1.22 (0.91-1.63) .18 0.82 (0.66-1.01) .06 1.13 (0.85-1.51) .39 1.58 (1.21-2.07) <.001
CMS-HCC risk score 0.86 (0.84-0.88) <.001 1.11 (1.03-1.19) .01 0.88 (0.84-0.92) <.001 1.15 (1.07-1.23) <.001 1.00 (0.91-1.10) .96

Abbreviations: ADI, Area Deprivation Index; CHF, congestive heart failure; CMS-HCC, Centers for Medicare & Medicaid Services–Hierarchical Condition Category; COPD; chronic obstructive pulmonary disease; HR, hazard ratio; MI, myocardial infarction; MIS, minimally invasive surgery; NA, not applicable; OR, odds ratio; TIA, transient ischemic attack.

a

Models were adjusted for age, sex, race and ethnicity, Medicare-Medicaid dual eligibility, ADI, cancer side, diabetes, CHF, COPD, previous MI, previous stroke or TIA, end-stage kidney disease, and CMS-HCC score.